BullBD Old Apps Site
Home
Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

SQURPHARMA

All Eps Dividend Board Agm Q1 Q2 Q3

SQURPHARMA 09-Nov-2016

Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 10.11.2016 to 13.11.2016. Trading of the shares of the Company will remain suspended on record date i.e., 14.11.2016.

SQURPHARMA 08-Nov-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 13, 2016 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2016.

SQURPHARMA 17-Oct-2016

There will be no price limit on the trading of the shares of the Company today (17.10.2016) following its corporate declaration.

SQURPHARMA 17-Oct-2016

(continuation news of SQURPHARMA): The Company has also reported EPS of Tk. 14.80, NAV per share of Tk. 57.08 and NOCFPS of Tk. 15.88 for the 15 months period ended on June 30, 2016 which was Tk. 10.46, Tk. 44.95 and Tk. 12.21 respectively for 15 months period from Jan 2014 to March 2015. (end)

SQURPHARMA 17-Oct-2016

The Board of Directors has recommended 40% cash and 10% stock dividend for the 15 months period from April 01, 2015 to June 30, 2016. The Board has also approved Tk. 250.00 crore for BMRE, Capital Machineries and Lands for future expansion. Date of AGM: 13.12.2016, Time: 10:00 AM, Venue: Raowa Convention Hall-2, Mohakhali, DOHS, Dhaka. Record Date: 14.11.2016. (cont.)

SQURPHARMA 09-Oct-2016

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 16, 2016 at 3:30 PM to consider, among others, audited financial statements of the Company for the 15 months period from April 01, 2015 to June 30, 2016.

SQURPHARMA 04-May-2016

The Company has informed that The Board of Directors has decided, according to the Companies Act, 1994 and The Directives dated 27th April, 2016 of BSEC, to extend the Financial Year (FY) 2015-2016 of the Company by an additional period of 3 months comprising to 15 months period ending on 30th June, 2016 instead of 31st March, 2016 in order to comply with the uniform income year from July to June as per provision of Section 9 of the Finance Act, 2015.

SQURPHARMA 31-Jan-2016

(Q3 Un-audited): Consolidated EPS was Tk. 3.39 for October-December, 2015 as against Tk. 2.45 for October-December, 2014; Consolidated EPS was Tk. 9.48 for April-December, 2015 as against Tk. 6.77 for April-December, 2014. Consolidated NOCFPS was Tk. 12.59 for April-December, 2015 as against Tk. 7.75 for April-December, 2014. Consolidated NAV per share was Tk. 56.86 as of December 31, 2015 and Tk. 49.86 as of March 31, 2015.

SQURPHARMA 25-Jan-2016

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 28, 2016 at 3:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on December 31, 2015.

SQURPHARMA 28-Oct-2015

(Q2 Un-audited): Consolidated EPS was Tk. 3.18 for July-September, 2015 as against Tk. 2.09 for July-September, 2014; Consolidated EPS was Tk. 6.09 for April-September, 2015 as against Tk. 4.32 for April-September, 2014. Consolidated NOCFPS was Tk. 6.87 for April-September, 2015 as against Tk. 3.94 for April-September, 2014. Consolidated NAV per share was Tk. 53.37 as of September 30, 2015 and Tk. 49.86 as of March 31, 2015.

Previous Next page